Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Fulvestrant.
Amiodarone
The metabolism of Fulvestrant can be decreased when combined with Amiodarone.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Fulvestrant.
Advertisement
Apalutamide
The serum concentration of Fulvestrant can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Fulvestrant can be increased when it is combined with Aprepitant.
Atazanavir
The metabolism of Fulvestrant can be decreased when combined with Atazanavir.
Advertisement
Atomoxetine
The metabolism of Fulvestrant can be decreased when combined with Atomoxetine.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Fulvestrant.
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Fulvestrant.
Advertisement
Boceprevir
The metabolism of Fulvestrant can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Fulvestrant can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Fulvestrant can be decreased when it is combined with Bosentan.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Fulvestrant.
Carbamazepine
The metabolism of Fulvestrant can be increased when combined with Carbamazepine.
Ceritinib
The serum concentration of Fulvestrant can be increased when it is combined with Ceritinib.
Clarithromycin
The metabolism of Fulvestrant can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Fulvestrant can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Fulvestrant can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Fulvestrant can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Fulvestrant.
Crizotinib
The metabolism of Fulvestrant can be decreased when combined with Crizotinib.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Fulvestrant.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Fulvestrant.
Cyclosporine
The metabolism of Fulvestrant can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Fulvestrant can be decreased when it is combined with Dabrafenib.
Darunavir
The metabolism of Fulvestrant can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Fulvestrant can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Fulvestrant can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Fulvestrant can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Fulvestrant can be decreased when combined with Delavirdine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Fulvestrant.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Fulvestrant.
Digoxin
Digoxin may decrease the cardiotoxic activities of Fulvestrant.
Dihydroergotamine
The metabolism of Fulvestrant can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Fulvestrant can be decreased when combined with Diltiazem.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Fulvestrant.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Fulvestrant.
Doxycycline
The metabolism of Fulvestrant can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Fulvestrant can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Fulvestrant can be decreased when combined with Dronedarone.
Enzalutamide
The serum concentration of Fulvestrant can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Fulvestrant can be decreased when combined with Erythromycin.
Fluconazole
The metabolism of Fulvestrant can be decreased when combined with Fluconazole.
Fluvoxamine
The metabolism of Fulvestrant can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Fulvestrant can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Fulvestrant can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Fulvestrant can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Fulvestrant can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Fulvestrant can be increased when it is combined with Fusidic Acid.
Hypoxis hemerocallidea root extract
The serum concentration of Fulvestrant can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Fulvestrant can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Fulvestrant can be decreased when combined with Imatinib.
Indinavir
The metabolism of Fulvestrant can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Fulvestrant can be decreased when combined with Indinavir.
Isavuconazole
The serum concentration of Fulvestrant can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Fulvestrant can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Fulvestrant can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Fulvestrant can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Fulvestrant can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Fulvestrant can be decreased when combined with Ketoconazole.
Lopinavir
The metabolism of Fulvestrant can be decreased when combined with Lopinavir.
Lovastatin
The metabolism of Fulvestrant can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Fulvestrant can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Fulvestrant can be increased when combined with Lumacaftor.
Mifepristone
The serum concentration of Fulvestrant can be increased when it is combined with Mifepristone.
Mitotane
The serum concentration of Fulvestrant can be decreased when it is combined with Mitotane.
Nefazodone
The metabolism of Fulvestrant can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Fulvestrant can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Fulvestrant can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Fulvestrant can be increased when combined with Nevirapine.
Nilotinib
The metabolism of Fulvestrant can be decreased when combined with Nilotinib.
Olaparib
The metabolism of Fulvestrant can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Fulvestrant can be increased when it is combined with Osimertinib.
Ouabain
Ouabain may decrease the cardiotoxic activities of Fulvestrant.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Fulvestrant.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Fulvestrant.
Palbociclib
The serum concentration of Fulvestrant can be increased when it is combined with Palbociclib.
Pentobarbital
The metabolism of Fulvestrant can be increased when combined with Pentobarbital.
Phenobarbital
The metabolism of Fulvestrant can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Fulvestrant can be increased when combined with Phenytoin.
Posaconazole
The metabolism of Fulvestrant can be decreased when combined with Posaconazole.
Primidone
The metabolism of Fulvestrant can be increased when combined with Primidone.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Fulvestrant.
Ranolazine
The metabolism of Fulvestrant can be decreased when combined with Ranolazine.
Rifabutin
The metabolism of Fulvestrant can be increased when combined with Rifabutin.
Rifampin
The metabolism of Fulvestrant can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Fulvestrant can be increased when combined with Rifapentine.
Rucaparib
The metabolism of Fulvestrant can be decreased when combined with Rucaparib.
Saquinavir
The metabolism of Fulvestrant can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Fulvestrant can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Fulvestrant can be decreased when used in combination with Sarilumab.
Sildenafil
The metabolism of Fulvestrant can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Fulvestrant can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Fulvestrant can be increased when it is combined with Simeprevir.
ST. JOHN'S WORT EXTRACT
The serum concentration of Fulvestrant can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Fulvestrant can be decreased when combined with Sulfisoxazole.
Telaprevir
The metabolism of Fulvestrant can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Fulvestrant can be decreased when combined with Telithromycin.
Ticlopidine
The metabolism of Fulvestrant can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Fulvestrant can be decreased when it is combined with Tocilizumab.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Fulvestrant.
Vemurafenib
The serum concentration of Fulvestrant can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Fulvestrant can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Fulvestrant can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Fulvestrant can be decreased when combined with Voriconazole.
Ziprasidone
The metabolism of Fulvestrant can be decreased when combined with Ziprasidone.
